Nexplanon 68 MG implants

Ended Awarded

Contract number
SPE2DR26FQRC9
Awardee
Awarding agency
Obligated
$8,645

Award facts

Contract value 100% obligated
$8,644.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on June 18, 2026, for Nexplanon 68 mg implants, with a ceiling value of $8,644.60 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business serving as the regional prime vendor under PPV-G GEN V's single-award indefinite delivery contract (SPE2DX), which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of performance is Park Ridge, Illinois. The order is firm fixed price with an ultimate completion date of July 13, 2026.

Quick answers

Who was awarded contract SPE2DR26FQRC9?

SPE2DR26FQRC9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2026.

How much is contract SPE2DR26FQRC9 worth?

The government has obligated $8,645 on SPE2DR26FQRC9.

Is contract SPE2DR26FQRC9 an order under another contract?

Yes. SPE2DR26FQRC9 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.

Was contract SPE2DR26FQRC9 competed?

The extent of competition for SPE2DR26FQRC9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login